ask="2.80"
ask_size="400"
average_daily_volume="948733"
bid="2.21"
bid_size="2300"
book_value="0.32"
change="-0.02"
change_from_200_day_moving_average="0.56"
change_from_50_day_moving_average="0.19"
change_from_52_week_high="-0.19"
change_From_52_week_low="1.81"
change_in_percent="-0.80%"
close="2.48"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.17"
ebitda="-24.62M"
eps_estimate_current_year="-0.17"
eps_estimate_next_quarter="-0.04"
eps_estimate_next_year="-0.10"
ex_dividend_date="N/A"
float_shares="116713000"
high="2.55"
high_52_weeks="2.67"
last_trade_date="3/6/2017"
last_trade_price="2.48"
last_trade_size="2620"
last_trade_time="4:00pm"
low="2.43"
low_52_weeks="0.67"
market_capitalization="384.61M"
moving_average_200_day="1.92"
moving_average_50_day="2.29"
name="Antares Pharma
Inc."
notes="N/A"
one_year_target_price="3.00"
open="2.50"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="+29.23%"
percent_change_from_50_day_moving_average="+8.20%"
percent_change_from_52_week_high="-7.12%"
percent_change_from_52_week_low="+270.15%"
previous_close="2.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.91"
price_per_sales="7.78"
revenue="49.83M"
shares_outstanding="155086000"
short_ratio="2.70"
stock_exchange="NCM"
symbol="ATRS"
volume="697110"
weeks_range_52="0.67 - 2.67"
